VET EXCLUSIVE
Assured administration only by a vet
1 YEAR FLEA AND TICK PROTECTION
Simple and convenient, guaranteed compliance
UNIQUE CRYSTAL FORMULATION
World first innovation
Unleash the power of fluralaner
BRAVECTO QUANTUM® uses the same trusted active ingredient veterinarians have been prescribing for nearly a decade.
- Each dose contains a unique suspension of crystallised fluralaner
- Crystals dissolve slowly, providing 1 year of non-stop flea and tick protection
- A multi-dose vial for precision dosing of dogs of all sizes
Veterinary administration delivers compliance and convenience.
KILL FLEAS AND TICKS FOR A FULL YEAR
- Dogs 6 months or older with a single injection*.
- For the treatment of existing flea (Ctenocephalides felis) and tick (Haemaphysalis longicornis) infestations.
- For the control of new flea (Ctenocephalides felis) and tick (Haemaphysalis longicornis) infestations for 12 months (1 year).
- Part of a treatment strategy for the control of flea allergy dermatitis (FAD).
*15 mg fluralaner/kg body weight.
Unleash the power of crystallised fluralaner
BRAVECTO QUANTUM® is a ground-breaking injectable suspension of fluralaner crystals. Following subcutaneous injection, the innovative crystal structures slowly dissolve and fluralaner is continuously released from the injection site, allowing it to be sustained over a period of 12 months.4
100% flea efficacy at 48 hours post treatment4
- Pen onset of efficacy study.4
- 48 healthy pure- and mixed-breed dogs were randomly assigned to 3 untreated control groups (24 dogs) or 3 BRAVECTO QUANTUM treatment groups (24 dogs).
- Each dog was infested with fleas 48 hours prior to treatment.
- Flea counts and egg collections were performed 24, 48, and 72 hours post treatment to evaluate onset of efficacy.
SUSTAINED FLEA EFFICACY
A single injection will control flea infestations on the dog within 2 days of treatment.1
From Day 6, 24-hour efficacy (the time at which fleas may start laying eggs) was sustained at 99.7-100% at each time point throughout the entire year.
After Day 7, no eggs from fleas on treated dogs were found at any subsequent time point throughout the one-year study period, confirming BRAVECTO QUANTUM breaks the flea life cycle by killing adult fleas before they lay eggs.
.
FLEA PROTECTION THAT LASTS
- 50 dogs in 29 households were enrolled in the study and treated with BRAVECTO QUANTUM on Day 0.
- Households ranged from 1 to 3 dogs on Day 0. Most households were 1 or 2 dog households.
- Initial flea counts ranged from 10 to 320 fleas.
PREVENT FLEA INFESTATIONS
- 24 dogs in 18 households were enrolled in the study and treated with BRAVECTO QUANTUM on Day 0.
- Households ranged from 1 to 3 dogs on Day 0. Most households were 1 or 2 dog households.
- Initial flea counts ranged from 8 to 62 fleas.
TRUST THE DEMONSTRATED
SAFETY OF FLURALANER
BRAVECTO QUANTUM was demonstrated to be safe in dogs at 5x the recommended dose when administered every 4 months for a total of 6 doses.4
- No systemic adverse effects attributable to administration were seen.
- The only treatment-related finding was limited to transient, non-painful injection site swellings that resolved over time, with no further treatment required.
- Fluralaner was well tolerated in Collies with a deficient multidrug-resistance protein 1 (MDR1 -/-) following single oral administration at 3 times the maximum recommended oral dose.
- The safety of BRAVECTO QUANTUM has not been established for use in breeding, pregnant or lactating dogs, or in dogs less than 6 months of age.
- Use with caution in dogs with pre-existing epilepsy.
- During laboratory and clinical field testing, no interactions between BRAVECTO QUANTUM and routinely used veterinary medicinal products were observed.
- Adverse reactions to the isoxazoline family of chemicals are rarely observed but may include vomiting, diarrhoea, lethargy, inappetence, itching and very rarely, neurological signs including tremors, ataxia and seizures. Most adverse reactions are self-limiting and of short duration.
BE THE FIRST TO OFFER YOUR CLIENTS
YEAR-LONG FLEA AND TICK PROTECTION WITH JUST ONE INJECTION
HOW TO MIX BRAVECTO QUANTUM
To ensure proper product preparation, follow the step-by-step mixing instructions carefully.
STEP 1
Shake the fluralaner powder vial to break up any aggregates prior to constitution.
STEP 2
Invert the vehicle vial at least 3 times until visibly uniform. The vehicle solution may be clear to cloudy in appearance.
STEP 3
Inject up to 14 mL of air into the vehicle vial using an 18 G needle and 20 mL syringe, then withdraw 15 mL of the vehicle from the vial.†
STEP 4
Insert a 25 G vent needle into the top of the fluralaner powder vial.‡
STEP 5
While rotating the vial horizontally in hand, slowly transfer the vehicle into the fluralaner powder vial to ensure complete wetting of the powder.
STEP 6
Remove the vent and transfer needles
from the fluralaner powder vial.
Discard needles.
STEP 7
Shake the vial vigorously for at least 30 seconds until a thoroughly mixed suspension of the fluralaner powder and vehicle is produced.
BRAVECTO QUANTUM IS NOW READY FOR ADMINISTRATION.
BRAVECTO QUANTUM ADMINISTRATION
- For use in dogs from 6 months of age only.
- For subcutaneous injection only.
- Dose rate of suspended product is 0.1 mL per kg body weight.
- Administer between the shoulder blades (dorsoscapular region) of the dog to provide a dose of 15 mg fluralaner per kg body weight.
- Do not inject suspended product intravenously.
FREQUENTLY ASKED QUESTIONS
There are no known contraindications when using medications concurrently with BRAVECTO QUANTUM. During laboratory and clinical field testing, no interactions between BRAVECTO QUANTUM and routinely used veterinary medicinal products were observed.
No. An 18-gauge needle must be used for injection as the fluralaner crystals in suspension may not pass adequately through smaller gauged needles. The suspension should be stored at room temperature and may avoid the discomfort associated with injecting a refrigerated product.
No. To treat and control ear mites, demodex mites or sarcoptic mange, please use Bravecto Chew or Bravecto Spot-on for Dogs.
Dogs 6 months of age or older, can commence treatment at anytime they are unprotected against fleas and ticks.
BRAVECTO QUANTUM has not been evaluated in cats and therefore its use is not recommended.
To avoid dogs outgrowing the BRAVECTO QUANTUM dose, studies were conducted in dogs 6 months of age or older. Bravecto Chew and Bravecto Spot-on for Dogs can be used for puppies from 8 weeks of age and greater than 2 kg.
Once the fluralaner powder has been suspended, the BRAVECTO QUANTUM vial may be stored for up to 3 months at room temperature (below 30oC). Once drawn up into a syringe, the dose should be administered to the dog within 5 minutes to maintain a uniform suspension and accurate dosing.
A margin of safety study was performed and demonstrated safety at doses of 1x (15 mg/kg), 3x (45 mg/kg) and 5x (75 mg/kg) administered every 4 months for 6 consecutive doses. The only treatment-related finding was limited to transient, non-painful injection site swellings that resolved over time, with no further treatment required.
Concurrent use with BRAVECTO QUANTUM and other ectoparasiticides has not been studied, therefore the recommendation is to administer BRAVECTO QUANTUM at the end of the dosing interval of the current ectoparasiticide.